Literature DB >> 10914412

Neurology of systemic autoimmune disorders: a pediatric perspective.

N F Schor1.   

Abstract

Autoimmune disorders can involve patients of any age and organs of any organ system. The central and peripheral nervous systems are frequently among the targets of these diseases. Immune dysfunction often presents in childhood or adolescence. Among the autoimmune disorders that present during childhood and adolescence, systemic lupus erythematosus, dermatomyositis, and Behcet's disease affect the nervous system with some degree of frequency. Furthermore, although juvenile rheumatoid arthritis only rarely affects the nervous system during childhood, it and its adult-onset counterpart may have profound long-term neurological consequences. Both symptomatic and pathophysiologically aimed therapies are important in the treatment of the nervous system sequelae of systemic autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914412     DOI: 10.1053/pb.2000.6692

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  4 in total

1.  Antibody induction of lupus-like neuropsychiatric manifestations.

Authors:  David A Lawrence; Valerie J Bolivar; Chad A Hudson; Tapan K Mondal; Nina G Pabello
Journal:  J Neuroimmunol       Date:  2006-12-06       Impact factor: 3.478

2.  Damage did not independently influence mortality in childhood systemic lupus erythematosus.

Authors:  Simone Appenzeller; Roberto Marini; Lilian T L Costallat
Journal:  Rheumatol Int       Date:  2005-02-10       Impact factor: 2.631

Review 3.  Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015).

Authors:  Giulio Zuccoli; Michael Paul Yannes; Raffaele Nardone; Ariel Bailey; Amy Goldstein
Journal:  Neuroradiology       Date:  2015-07-31       Impact factor: 2.804

4.  Brain profiling in murine colitis and human epilepsy reveals neutrophils and TNFα as mediators of neuronal hyperexcitability.

Authors:  Sarah E Barnes; Kristy A Zera; Geoffrey T Ivison; Marion S Buckwalter; Edgar G Engleman
Journal:  J Neuroinflammation       Date:  2021-09-12       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.